生物製藥輔料市場規模、佔有率及成長分析（按產品、功能、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年全球生物製藥輔料市場規模價值 23 億美元，預計將從 2024 年的 24.3 億美元成長到 2032 年的 37.6 億美元，預測期內（2025-2032 年）的複合年成長率為 5.6%。

截至 2023 年 10 月，全球生物製藥輔料市場呈現穩步上升趨勢，這得益於對生物製藥的需求不斷增加、向個人化醫療的轉變以及生物技術和藥物輸送系統的創新。癌症和自體免疫疾病等慢性疾病的發生率日益上升，導致人們越來越需要標靶治療，以減少副作用並改善患者的治療效果。此外，與傳統的小分子藥物相比，生物製藥的使用趨勢明顯增多，再加上生物技術的進步，推動了對專用輔料的需求，以配合這些創新治療方法。然而，市場面臨著諸如複雜的法規環境、先進製造要求導致的高營運成本以及與傳統輔料相比生物製藥輔料的價格較高等挑戰，這些可能會阻礙其更廣泛的應用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

生物製藥輔料市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 碳水化合物
  • 葡萄糖
  • 澱粉
  • 蔗糖
• 多元醇
  • 甘露醇
  • 山梨醇
• 增溶劑和界面活性劑/乳化劑
  • 酯
  • 三酸甘油酯
• 特殊添加物

生物製藥輔料市場規模（按功能和複合年成長率） (2025-2032)

• 市場概況
• 黏合劑
• 塗層
• 崩壞
• 潤滑劑及潤滑劑
• 藥用填充劑
• 防腐劑

生物製藥輔料市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 先進的傳動系統
• 口服
• 腸外
• 外用

生物製藥輔料市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 契約製造組織
• 製藥和生物技術公司

生物製藥輔料市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Merck KGaA（Germany）
• BASF SE（Germany）
• Evonik Industries AG（Germany）
• Roquette Freres（France）
• Colorcon, Inc.（USA）
• DFE Pharma（Germany）
• Avantor, Inc.（USA）
• Kerry Group plc（Ireland）
• Associated British Foods plc（UK）
• Wacker Chemie AG（Germany）
• Lubrizol Corporation（USA）
• J. Rettenmaier & Sohne GmbH+Co KG（Germany）
• SPI Pharma（USA）
• Fuji Chemical Industries Co., Ltd.（Japan）
• Meggle GmbH & Co. KG（Germany）
• Beneo GmbH（Germany）

結論和建議

Global Biopharmaceuticals Excipients Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.43 billion in 2024 to USD 3.76 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

As of October 2023, the global biopharmaceutical excipients market is on a steady upward trajectory, fueled by rising demand for biopharmaceutical drugs, a shift towards personalized medicine, and innovations in biotechnology and drug delivery systems. The increasing prevalence of chronic conditions like cancer and autoimmune disorders has heightened the need for targeted therapies, enhancing patient outcomes with fewer side effects. Furthermore, there is a notable preference for biologics over traditional small-molecule drugs, coupled with ongoing biotechnological advancements that drive the demand for specialized excipients tailored for these innovative therapies. However, the market faces challenges including a complex regulatory environment, high operational costs due to advanced manufacturing requirements, and the elevated price of biopharmaceutical excipients compared to their conventional counterparts, potentially hindering broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segmental Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market is being significantly driven by the escalating demand for biopharmaceuticals, primarily fueled by the rising incidence of chronic diseases and an aging population. As more individuals seek effective therapeutic solutions, the preference for biologics has intensified due to their targeted approach and enhanced efficacy. This shift necessitates the incorporation of specialized excipients that improve drug attributes such as stability, solubility, and delivery mechanisms. Consequently, the continuous innovation and adaptation of excipients tailored for biopharmaceutical applications are vital in meeting the evolving requirements of the pharmaceutical industry, thereby fostering market growth.

Restraints in the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market faces significant challenges due to a complex regulatory landscape. The stringent and intricate approval processes for biopharmaceutical drugs require extensive testing and validation of excipients utilized in biologic formulations. This complexity compels excipient manufacturers to navigate a multitude of regulatory standards, which can be time-consuming and resource-intensive. As a result, these regulatory hurdles may impede the growth and expansion of the market, making it difficult for manufacturers to introduce new products and adapt to evolving compliance demands. Consequently, the intricate nature of regulatory requirements presents a substantial restraint on the biopharmaceutical excipients market.

Market Trends of the Global Biopharmaceuticals Excipients Market

The global biopharmaceuticals excipients market is witnessing a significant trend driven by the increasing demand for specialty and functional excipients. As biologic drugs evolve and expand in complexity, the need for excipients that cater to specific formulation requirements has surged. These specialty excipients, designed for functionalities such as protein stabilization, controlled drug release, and enhanced solubility, are gaining traction among manufacturers striving to optimize therapeutic efficacy and patient outcomes. This shift not only underscores the pivotal role of excipients in drug development but also reflects the biopharmaceutical industry's commitment to innovation and precision in delivering advanced healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2025-2032)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2025-2032)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2025-2032)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations